6533b86dfe1ef96bd12c950a

RESEARCH PRODUCT

Liver-infiltrating and circulating CD4+ T cells in chronic hepatitis C: immunodominant epitopes, HLA-restriction and functional significance.

G. GerkenHanns F. LöhrHans-peter DienesK H Meyer Zum BüschenfeldeJörg F. SchlaakS Kollmannsperger

subject

CD4-Positive T-LymphocytesHepatitis C virusT cellMolecular Sequence DataBiologymedicine.disease_causePeripheral blood mononuclear cellPolymerase Chain ReactionVirusLiver diseaseEpitopesInterferon-gammaImmune systemTransformation GeneticHLA AntigensmedicineHumansAmino Acid SequenceHepatitisB-LymphocytesHepatologyTumor Necrosis Factor-alphaT lymphocytemedicine.diseaseVirologyHepatitis CPeptide Fragmentsmedicine.anatomical_structureLiverRNA ViralInterleukin-4MitogensCell Division

description

The aim was to assess the specificity and functional significance of liver-infiltrating and peripheral blood T cells in chronic hepatitis C. Peripheral blood mononuclear cells hepatitis C virus from 50 of 58 (86.2%) patients with chronic hepatitis C virus infection and 6 of 28 (21.4%) controls showed a proliferative T cell response to at least one of 16 synthetic peptides covering highly conserved regions of the core, envelope (El) and non-structural regions (NS4) of hepatitis C virus. However, six immunodominant peptides were exclusively recognized by the proliferating blood mononuclear cells from 46 patients with chronic hepatitis C virus infection (79.3%). Fine specificity and HLA-restriction were studied with 15 peptide-specific CD4+ T cell lines and 23 T cell clones isolated from liver tissue and peripheral blood of 12 patients with chronic hepatitis C. It was demonstrated that the peptide-specific response of CD4+ T cells was restricted to the presence of autologous accessory cells and HLA-DR and -DP molecules. Eight peptide-specific T cell lines and five T cell clones derived from liver tissue and peripheral blood, released interferon-gamma (200-6600 pg/ml) and tumor necrosis factor-alpha (100-400 pg/ml) and no or little interleukin-4 (< 140 pg/ml) after peptide-specific or mitogeneic stimulation, thus resembling a Th1-like cytokine profile. Patients with active liver disease showed significantly higher proliferative responses to hepatitis C virus core peptides than asymptomatic hepatitis C virus carriers or complete responders to interferon therapy. In conclusion, class II-restricted CD4+ T cell responses to some immunodominant epitopes within the hepatitis core region correlated with disease activity in chronic hepatitis C virus infection. Functionally, liver-infiltrating and peripheral blood T cells released Th1-like cytokines in response to the specific stimulus. Thus, it can be suggested that CD4+ T cells can mediate the pathogenesis of chronic hepatitis C virus induced liver disease.

10.1111/j.1600-0676.1996.tb00724.xhttps://pubmed.ncbi.nlm.nih.gov/8873004